Financial toxicity describes the financial burden and distress that can arise for patients, and
their family members, as a result of cancer treatment. It includes direct out-of-pocket costs for …

Surgery is a mainstay treatment for patients with solid tumours. However, despite surgical
resection with a curative intent and numerous advances in the effectiveness of (neo) …

Background In 2015, the second cycle of the CONCORD programme established global
surveillance of cancer survival as a metric of the effectiveness of health systems and to …

Objective: To perform the first randomized controlled trial to compare laparoscopic and open
liver resection. Summary Background Data: Laparoscopic liver resection is increasingly …

Importance Financial toxicity (FT) is the negative impact of cost of care on financial well-
being. Patients with breast cancer are at risk for incurring high out-of-pocket costs given the …

Background Worldwide data for cancer survival are scarce. We aimed to initiate worldwide
surveillance of cancer survival by central analysis of population-based registry data, as a …

Summary 23% of the total global burden of disease is attributable to disorders in people
aged 60 years and older. Although the proportion of the burden arising from older people (≥ …

Background: Out-of-pocket costs pose a substantial economic burden to cancer patients and
their families. The purpose of this study was to evaluate the literature on out-of-pocket costs …

Background Biologics have provided improved clinical benefits to patients, but they come at
a huge expense due to the high costs associated with their development and manufacturing …

Summary Background In 2008, 2· 45 million people were diagnosed with cancer and 1· 23
million died because of cancer in the 27 countries of the European Union (EU). We aimed to …